Boris B. Quednow

Boris B. Quednow is a Full Professor of Experimental Pharmacopsychology and Psychological Addiction Research at the University of Zurich, affiliated with the Department of Adult Psychiatry and Psychotherapy at the University Hospital of Psychiatry Zurich. His work focuses on the neurobiological and behavioral mechanisms underlying substance use disorders, stress, and addiction. He leads research in the zIReN network, investigating biomarkers (e.g., hair analysis), neuropharmacology, and translational clinical studies. Key interests include endocannabinoid systems, psychedelics, and neurofilament light chain biomarkers in psychiatric conditions.

His research integrates clinical trials (e.g., gamma-hydroxybutyrate for depression), neuroimaging (e.g., neuroaxonal changes in ECT), and longitudinal cohort studies on substance use behaviors. He collaborates with the Jacobs Center for Productive Youth Development and international partners to address developmental and social aspects of addiction. No specific awards are noted, but his contributions to forensic toxicology and drug policy are highlighted through publications.

Advising and grants are not explicitly listed, though his involvement in large-scale studies suggests significant grant support. He is associated with the zIReN-Team and z-proso group, focusing on interdisciplinary approaches to mental health and addiction research.